Our mission is dedicated to improving the application and success of hematopoietic cell transplantation and related cellular therapies. We strive to be the leading organization promoting research, education and clinical practice in the field.
Become a Member
ASTCT Talks features industry leaders coming together to tackle important subjects in the growing field of transplantation and cellular therapy. You can listen to ASTCT Talks on the following platforms: Spotify, Google Podcasts and Apple Podcasts.
Listen Here
Now Available! Access the latest issue of Transplantation and Cellular Therapy
Read the Journal
Access the latest news, session previews, and speaker spotlights from the 2025 Tandem Meetings.
Read More
Scientists believe prostaglandin F2 receptor negative regulator (PTGFRN) is a possible target for chimeric antigen receptor (CAR) T-cell therapy in patients with glioblastoma (GBM).
Researchers report the safety of a novel approach to insulate edited cells from chimeric antigen receptor (CAR) selection and attack.
View More
Check Out the Guideline
This live session will focus on two core topics in the field - CAR T and Gene Therapy. The faculty below will briefly present slides on their topic, and then answer questions and share their experiences from their institutions.
The Joint ASTCT + EBMT Basic and Translational Scientific Meeting is a 2.5-day conference focused on cutting-edge basic and translational biology in the field. The meeting focuses on fundamental themes and novel technologies with an emphasis on unpublished and innovative science.
Join ASTCT Director of Government Relations, Alycia Maloney, JD, and the reimbursement and policy advisors to ASTCT from Nimitt Consulting, for the Medicare FY 2026 IPPS Proposed Rule webinar.r on May 15 at 12 p.m. CDT.
More Meetings
Browse all Education